What does CUSIP 37611X100 represent in this 13F holders report?

CUSIP 37611X100 is the security identifier for DNA - RECURSION PHARMACEUTICALS INC - COMMON STOCK used to aggregate holder disclosures.

How many institutions held DNA - RECURSION PHARMACEUTICALS INC - COMMON STOCK in Q3 2023?

342 institutional investors reported DNA - RECURSION PHARMACEUTICALS INC - COMMON STOCK for Q3 2023. Use the holders table for investor-level position and value details.

RECURSION PHARMACEUTICALS INC - COMMON STOCK (DNA)

CUSIP: 37611X100

Q3 2023 13F Holders as of 30 Sep 2023

Security type / class: Equity / COMMON STOCK
Total 13F shares: 1,240,312,565
Total 13F value: $2,245,097,773
Share change: +28,600,148
Put/Call ratio: 118%
SEC-reported price per share: $1.81
Number of holders: 342
Value change: +$49,927,444
Number of buys: 190
Number of sells: 73
Shares outstanding: 518,011,600

Security key

37611X100

Report period

Q3 2023

Institutions

342

Top holders

DNA full security history Ownership snapshot Full 13F holder table Newer quarter: Q2 2026 RECURSION PHARMACEUTICALS, INC. SEC filings RECURSION PHARMACEUTICALS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 37611X100

Newer quarter: Q2 2026

Recent filing periods:

Q3 2026 Q2 2026

Ownership snapshot

Top reported holders of DNA - RECURSION PHARMACEUTICALS INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Lux Ventures IV, L.P.

Disclosed value leader

BAILLIE GIFFORD & CO

Comparable rows

0/15

Latest evidence

03 Jul 2023

3/4/5 13F Highest disclosed value: $635,890,710 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BAILLIE GIFFORD & CO has the largest disclosed position value at $635.89M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BAILLIE GIFFORD & CO's linked filing trail.

Disclosed position value Top 5

Lux Ventures IV, L.P. $137.71M

Mubadala Investment Co PJSC $137.33M

Zachary Bogue $39.51M

MIC Capital Partners (Public) Par... $14.69M

BAILLIE GIFFORD & CO $635.89M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Lux Ventures IV, L.P.	3/4/5 Former 10% Owner 3/4/5	— denominator unverified	$137,710,376 13,021,519 shares	—	07 Dec 2021
Mubadala Investment Co PJSC	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$137,333,970 12,985,927 shares	—	02 Mar 2023
Zachary Bogue	3/4/5 Director, 10%+ Owner 3/4/5	— denominator unverified	$39,514,048 3,736,341 shares	—	03 Jul 2023
MIC Capital Partners (Public) Parallel Cayman, LP	3/4/5 10%+ Owner 3/4/5	— denominator unverified	$14,688,335 1,388,889 shares	—	01 Nov 2021
BAILLIE GIFFORD & CO	13F Company 13F	— mixed-class rows	$635,890,710 266,179,035 shares mixed-class rows	—	30 Jun 2023
ARK Investment Management LLC	13F Company 13F	— mixed-class rows	$351,130,844 174,488,044 shares mixed-class rows	—	30 Jun 2023

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

342

1,240,312,565

Rows available

342

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2023 vs Q2 2026 Across Filers

Q2 2026 holders

Q3 2023 holders

342

Holder diff

341

Investor	Q2 2026 Shares	Q3 2023 Shares	Share Diff	Share Chg %	Q2 2026 value	Q3 2023 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend